News

June 27 is National HIV Testing Day, a time to encourage people to learn their status. Early HIV diagnosis is critical, ...
The biggest barrier for those with HIV getting the care they need is not knowing they need it. In response, DAP Health is ...
The FDA approved Lenacapavir, the first twice-a-year injection to prevent HIV, marking a historic step in public health.
In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community ...
Drawing from 19 studies across sub-Saharan Africa and select global contexts, the review finds that RHIS remain largely ...
But modern HIV protection platform Mistr PrEP is helping change that — by making protection smarter, easier, and actually ...
Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
Oil prices jumped on Monday to their highest since January as the United States' weekend move to join Israel in attacking ...